Inventor · disambiguated record
James Rottman
Also filed as: ROTTMAN JAMES · ROTTMAN JAMES B · ROTTMAN JAMES BRIAN
15 granted patents·7 pending applications·174 citations·filing 1999–2024
93Inventor score
Top patents by PatentIndex Score
22 records- 0193US7538211B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX CORP·Filed 2005·Granted May 26, 2009·33 cites·7 claims
- 0292US7803931B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX CORP·Filed 2005·Granted Sep 28, 2010·19 cites·5 claims
- 0392US7579456B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX CORP·Filed 2006·Granted Aug 25, 2009·24 cites·6 claims
- 0489US6245332B1Modulation of systemic memory T cell traffickingUNIV LELAND STANFORD JUNIOR·Filed 1999·Granted Jun 12, 2001·65 cites·15 claims
- 0588US8236773B2Aptamer therapeutics useful in the treatment of complement-related disordersBENEDICT CLAUDE·Filed 2006·Granted Aug 7, 2012·9 cites·10 claims
- 0687US10947544B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2019·Granted Mar 16, 2021·1 cites·5 claims
- 0786US12397028B2Adoptive cellular therapyREGENERON PHARMA·Filed 2024·Granted Aug 26, 2025·0 cites·11 claims
- 0886US8436164B2Aptamer therapeutics useful in the treatment of complement-related disordersBENEDICT CLAUDE·Filed 2012·Granted May 7, 2013·6 cites·15 claims
- 0984US12036256B2Adoptive cellular therapyREGENERON PHARMA·Filed 2019·Granted Jul 16, 2024·1 cites·26 claims
- 1084US9617546B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2014·Granted Apr 11, 2017·4 cites·5 claims
- 1177US11913000B2Aptamer therapeutics useful in the treatment of complement-related disordersIVERIC BIO INC·Filed 2021·Granted Feb 27, 2024·0 cites·10 claims
- 1277US9175078B2Ferroportin antibodies and methods of useARVEDSON TARA·Filed 2009·Granted Nov 3, 2015·6 cites·53 claims
- 1375US8946184B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2013·Granted Feb 3, 2015·1 cites·20 claims
- 1473US6881406B2Modulation of systemic memory T cell traffickingMILLENNIUM PHARM INC·Filed 2001·Granted Apr 19, 2005·5 cites·14 claims
- 1562US2018030446A1Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2017·Application pending·0 cites
- 1653US2005169918A1Modulation of systemic memory T cell traffickingFiled 2005·Application pending·0 cites
- 1751US2022362304A1Adoptive cell therapy2SEVENTY BIO INC·Filed 2020·Application pending·0 cites
- 1849US2003144193A1TANGO 197 and TANGO 216 compositions and methodsFiled 2002·Application pending·0 cites
- 1949US2004001831A1Methods and compositions for the diagnosis and treatment of demyelinating inflammatory disordersMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 2047US2003134786A1TANGO 197 and TANGO 216 compositions and methodsFiled 2001·Application pending·0 cites
- 2146US9688759B2Ferroportin antibodies and methods of useAMGEN INC·Filed 2015·Granted Jun 27, 2017·0 cites·12 claims
- 2236US2002054875A1Therapeutic methods that target fractalkine or CX3CR1UNIV NORTHWESTERN·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Rottman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →